Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours Β· Estimated delivery Oct 14 - Oct 19
Potential Heart Failure Benefits: Offers advantages for heart failure patients, particularly those with preserved ejection fraction
If needed, the dosage is increased by 2.5 mg increments every 4 weeks until you reach the maintenance dose
Lixisenatide (Adlyxin) A once-daily injection approved in 2016 for type 2 diabetes
Evidence is emerging regarding the potential benefits of combined treatment with both an SGLT2i and a GLP-1 RA on outcomes
Important Notice This product is intended for laboratory research use only
Effectiveness: 57 % weight loss in diabetes patients
US$ 22.15
US$ 22.69
US$ 21.13
US$ 21.74
